Halozyme
HALO
162 hedge funds and large institutions have $1.26B invested in Halozyme in 2016 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 49 increasing their positions, 52 reducing their positions, and 23 closing their positions.
285% more call options, than puts
Call options by funds: $17.5M | Put options by funds: $4.54M
38% more capital invested
Capital invested by funds: $909M → $1.26B (+$346M)
4% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 23
1% more funds holding
Funds holding: 161 → 162 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 52
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.4M |
| 2 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$11.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.04M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$4.27M |
| 5 |
First Eagle Investment Management
New York
|
+$3.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$6.11M |
| 2 |
Bank of New York Mellon
New York
|
-$5.69M |
| 3 |
QF
QVT Financial
New York
|
-$4.32M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$3.59M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.59M |
HALO Hedge Fund Activity: Q3 2016 in Review
162 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q3 2016, worth a combined $1.26B — up 38% from $909M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new HALO positions and 23 closed out — a net gain of 1 holder — while 49 added to existing stakes and 52 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $11.4M. The largest seller was Lombard Odier Asset Management (USA), cutting an estimated $6.11M.
- 162 institutional investors held Halozyme (HALO) as of Q3 2016, up from 161 in Q2 2016.
- Funds reported $1.26B of Halozyme stock for Q3 2016, up 38% quarter-over-quarter.
- 24 funds opened new Halozyme positions in Q3 2016 and 23 closed out, a net change of +1 holder.
- The largest Halozyme buyer in Q3 2016 was Fidelity Investments, an estimated $11.4M added.
- The largest Halozyme seller in Q3 2016 was Lombard Odier Asset Management (USA), an estimated $6.11M sold.
Based on aggregated 13F filings for Q3 2016.